• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Open Forum Infect Dis . Development of a Standardized Data Collection Tool for Evaluation and Management of Coronavirus Disease 2019

tetano

Editor, Senior Moderator
Open Forum Infect Dis


. 2020 Jul 29;7(9):ofaa320.
doi: 10.1093/ofid/ofaa320. eCollection 2020 Sep.
Development of a Standardized Data Collection Tool for Evaluation and Management of Coronavirus Disease 2019


Stephen R Morris[SUP] 1 [/SUP], Yoichiro Natori[SUP] 2 [/SUP], Douglas Salguero[SUP] 3 [/SUP], Alejandro Mantero[SUP] 4 [/SUP], Ruixuan Ma[SUP] 4 [/SUP], Daniela F de Lima Corvino[SUP] 1 [/SUP], Anmary Fernandez[SUP] 1 [/SUP], Alex Lazo[SUP] 1 [/SUP], Christine A Vu[SUP] 5 [/SUP], Lauren Bjork[SUP] 6 [/SUP], David Serota[SUP] 3 [/SUP], Jennifer Quevedo[SUP] 7 [/SUP], Ana Vega[SUP] 5 [/SUP], Meshell Maxam[SUP] 5 [/SUP], Kailynn DeRonde[SUP] 5 [/SUP], Pablo Barreiro[SUP] 8 [/SUP], Patricia Raccamarich[SUP] 3 [/SUP], Maria Romero Alvarez[SUP] 1 [/SUP], Dimitra Skiada[SUP] 1 [/SUP], Shuba Balan[SUP] 1 [/SUP], Maya Ramanathan[SUP] 1 [/SUP], Gregory Holt[SUP] 9 [/SUP], Jose Gonzales-Zamora[SUP] 3 [/SUP], Gio J Baracco[SUP] 3 10 [/SUP], Susanne Doblecki-Lewis[SUP] 3 [/SUP], Lilian M Abbo[SUP] 3 [/SUP], Paola N Lichtenberger[SUP] 3 10 [/SUP], Maria L Alcaide[SUP] 3 [/SUP]



Affiliations

Abstract

Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 ) is responsible for coronavirus disease 2019 (COVID-19), a disease that had not been previously described and for which clinicians need to rapidly adapt their daily practice. The novelty of SARS-CoV-2 produced significant gaps in harmonization of definitions, data collection, and outcome reporting to identify patients who would benefit from potential interventions.
Methods: We describe a multicenter collaboration to develop a comprehensive data collection tool for the evaluation and management of COVID-19 in hospitalized patients. The proposed tool was developed by a multidisciplinary working group of infectious disease physicians, intensivists, and infectious diseases/antimicrobial stewardship pharmacists. The working group regularly reviewed literature to select important patient characteristics, diagnostics, and outcomes for inclusion. The data collection tool consisted of spreadsheets developed to collect data from the electronic medical record and track the clinical course after treatments.
Results: Data collection focused on demographics and exposure epidemiology, prior medical history and medications, signs and symptoms, diagnostic test results, interventions, clinical outcomes, and complications. During the pilot validation phase, there was <10% missing data for most domains and components. Team members noted improved efficiency and decision making by using the tool during interdisciplinary rounds.
Conclusions: We present the development of a COVID-19 data collection tool and propose its use to effectively assemble harmonized data of hospitalized individuals with COVID-19. This tool can be used by clinicians, researchers, and quality improvement healthcare teams. It has the potential to facilitate interdisciplinary rounds, provide comparisons across different hospitalized populations, and adapt to emerging challenges posed by the pandemic.

Keywords: coronavirus-19; data collection tool; hospitalized.
 
Back
Top Bottom